
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study”, Ann Rheum Dis, vol. 70, pp. 134-8, 2011.
, “Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink”, Copd, vol. 15, pp. 177-184, 2018.
, “The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database”, Osteoarthritis Cartilage, vol. 19, pp. 29-36, 2011.
, “Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database”, Bmj, vol. 339, p. b3999, 2009.
, “Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use”, Arthritis Rheum, vol. 63, pp. 992-1001, 2011.
, “Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink”, Osteoarthritis Cartilage, vol. 23, pp. 594-600, 2015.
, “Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study”, Ann Rheum Dis, vol. 74, pp. 557-63, 2015.
, “The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database”, Osteoarthritis Cartilage, vol. 20, pp. 519-24, 2012.
, “Mortality in Wegener's granulomatosis: a bimodal pattern”, Rheumatology (Oxford), vol. 50, pp. 697-702, 2011.
, “A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database”, BMJ Open, vol. 3, p. e003614, 2013.
, “Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study”, BJU Int, vol. 117, pp. 801-8, 2016.
, “Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database”, Pharmacoepidemiol Drug Saf, 2020.
, “The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK”, Ann Rheum Dis, vol. 74, pp. 129-35, 2015.
, “Temporal trends in hip and knee replacement in the United Kingdom: 1991 to 2006”, J Bone Joint Surg Br, vol. 92, pp. 130-5, 2010.
, “Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study”, J Rheumatol, vol. 43, pp. 1085-92, 2016.
,